{"id":"https://openalex.org/W1908430636","doi":"https://doi.org/10.1593/neo.13812","title":"Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma","display_name":"Allosteric MEK1/2 Inhibitor Refametinib (BAY 86-9766) in Combination with Sorafenib Exhibits Antitumor Activity in Preclinical Murine and Rat Models of Hepatocellular Carcinoma","publication_year":2013,"publication_date":"2013-10-01","ids":{"openalex":"https://openalex.org/W1908430636","doi":"https://doi.org/10.1593/neo.13812","mag":"1908430636","pmid":"https://pubmed.ncbi.nlm.nih.gov/24204195","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3819632"},"language":"en","primary_location":{"id":"doi:10.1593/neo.13812","doi":"https://doi.org/10.1593/neo.13812","is_oa":true,"landing_page_url":"https://doi.org/10.1593/neo.13812","pdf_url":null,"source":{"id":"https://openalex.org/S20008548","display_name":"Neoplasia","issn_l":"1476-5586","issn":["1476-5586","1522-8002"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neoplasia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1593/neo.13812","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059197250","display_name":"Roberta Schmieder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Roberta Schmieder","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044229103","display_name":"Florian Puehler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Florian Puehler","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032703270","display_name":"Roland Neuhaus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Roland Neuhaus","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031249756","display_name":"Maria Kissel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Maria Kissel","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex A Adjei","raw_affiliation_strings":["Roswell Park Cancer Institute, Buffalo, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Buffalo, NY","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003967456","display_name":"Jeffrey N. Miner","orcid":"https://orcid.org/0000-0001-5603-8807","observed_orcids":["https://orcid.org/0000-0001-5603-8807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey N Miner","raw_affiliation_strings":["Ardea Biosciences, Inc, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardea Biosciences, Inc, San Diego, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009359386","display_name":"Dominik Mumberg","orcid":"https://orcid.org/0000-0002-6670-1497","observed_orcids":["https://orcid.org/0000-0002-6670-1497"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Mumberg","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051451842","display_name":"Karl B. Ziegelbauer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karl Ziegelbauer","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109212479","display_name":"Arne Scholz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Arne Scholz","raw_affiliation_strings":["Global Drug Discovery, Bayer Healthcare, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Drug Discovery, Bayer Healthcare, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5044229103"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":3530,"currency":"USD","value_usd":3530},"apc_paid":{"value":3530,"currency":"USD","value_usd":3530},"fwci":4.3768,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.94479604,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"15","issue":"10","first_page":"1161","last_page":"IN24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9355000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/refametinib","display_name":"refametinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9449999928474426},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7599999904632568},{"id":"https://openalex.org/keywords/allosteric-kinase-inhibitors","display_name":"allosteric kinase inhibitors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8629999756813049},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7549999952316284},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":0.8360000252723694},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.9259999990463257}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9584386348724365},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6712393164634705},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.665869414806366},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5268002152442932},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4882400333881378},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4729340374469757},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46107912063598633},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4520799517631531},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4490927457809448},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32451486587524414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27398568391799927},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08852899074554443},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000494","descriptor_name":"Allosteric Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004159","descriptor_name":"Diphenylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004159","descriptor_name":"Diphenylamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004159","descriptor_name":"Diphenylamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064591","descriptor_name":"Allografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1593/neo.13812","doi":"https://doi.org/10.1593/neo.13812","is_oa":true,"landing_page_url":"https://doi.org/10.1593/neo.13812","pdf_url":null,"source":{"id":"https://openalex.org/S20008548","display_name":"Neoplasia","issn_l":"1476-5586","issn":["1476-5586","1522-8002"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neoplasia","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2809029","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3819632","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3819632","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3819632","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neoplasia","raw_type":"Text"},{"id":"pmid:24204195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24204195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neoplasia (New York, N.Y.)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:7b75d1b09ebc420588d3c375c24ac183","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7b75d1b09ebc420588d3c375c24ac183","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neoplasia: An International Journal for Oncology Research, Vol 15, Iss 10, Pp 1161-1171 (2013)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1593/neo.13812","doi":"https://doi.org/10.1593/neo.13812","is_oa":true,"landing_page_url":"https://doi.org/10.1593/neo.13812","pdf_url":null,"source":{"id":"https://openalex.org/S20008548","display_name":"Neoplasia","issn_l":"1476-5586","issn":["1476-5586","1522-8002"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neoplasia","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306091","display_name":"American Association for Cancer Research","ror":"https://ror.org/02fnpv153"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W36141288","https://openalex.org/W165173872","https://openalex.org/W1513001061","https://openalex.org/W1970039331","https://openalex.org/W1971673379","https://openalex.org/W1971837077","https://openalex.org/W1974091059","https://openalex.org/W1981388207","https://openalex.org/W1989145928","https://openalex.org/W1994193851","https://openalex.org/W2004295816","https://openalex.org/W2011826559","https://openalex.org/W2027053992","https://openalex.org/W2051213986","https://openalex.org/W2057185004","https://openalex.org/W2058388078","https://openalex.org/W2063139884","https://openalex.org/W2065909963","https://openalex.org/W2070686081","https://openalex.org/W2074867181","https://openalex.org/W2075702083","https://openalex.org/W2080151878","https://openalex.org/W2080737967","https://openalex.org/W2080931115","https://openalex.org/W2085657688","https://openalex.org/W2101624426","https://openalex.org/W2103562758","https://openalex.org/W2106787323","https://openalex.org/W2112463549","https://openalex.org/W2126568409","https://openalex.org/W2136745780","https://openalex.org/W2137990944","https://openalex.org/W2140219168","https://openalex.org/W2140765540","https://openalex.org/W2145595073","https://openalex.org/W2346857231","https://openalex.org/W2409793681","https://openalex.org/W2414583326","https://openalex.org/W3021431521","https://openalex.org/W3139763557","https://openalex.org/W6713929388","https://openalex.org/W6715596821"],"related_works":["https://openalex.org/W2068662993","https://openalex.org/W2090065330","https://openalex.org/W2599204401","https://openalex.org/W4230674271","https://openalex.org/W3044622989","https://openalex.org/W2009859985","https://openalex.org/W2091957929","https://openalex.org/W2023447208","https://openalex.org/W2114752093","https://openalex.org/W2526393290"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"objectives":[2],"of":[3,44,82,124,177,185,205,244],"the":[4,9,71,125,171,175,186,201,240],"study":[5],"were":[6,52,74,85,153,161],"to":[7,106,183,200],"evaluate":[8],"allosteric":[10],"mitogen-activated":[11],"protein":[12],"kinase":[13,14,128],"(MEK)":[15],"inhibitor":[16],"BAY":[17,45,88,109,130,178,195,219,245],"86-9766":[18,46,89,110,131,179,196,220,246],"in":[19,22,26,38,54,64,68,94,116,134,157,163,216,229,233,249],"monotherapy":[20],"and":[21,28,47,80,121,140,149,167,180,211,226,247],"combination":[23,158,176,230],"with":[24,34,50,98,114,159,231],"sorafenib":[25,51,115,160,181,232,248],"orthotopic":[27],"subcutaneous":[29],"hepatocellular":[30],"carcinoma":[31],"(HCC)":[32],"models":[33],"different":[35],"underlying":[36,202],"etiologies":[37],"two":[39],"species.":[40],"DESIGN:":[41],"Antiproliferative":[42],"potential":[43],"synergistic":[48,113],"effects":[49,156],"studied":[53,63],"several":[55],"HCC":[56,72,95,235],"cell":[57,96,119,209],"lines.":[58],"Relevant":[59],"pathway":[60,173],"signaling":[61,172],"was":[62,111,214],"MH3924a":[65],"cells.":[66],"For":[67],"vivo":[69],"testing,":[70],"cells":[73],"implanted":[75],"subcutaneously":[76],"or":[77],"orthotopically.":[78],"Survival":[79],"mode":[81],"action":[83],"(MoA)":[84],"analyzed.":[86],"RESULTS:":[87],"exhibited":[90],"potent":[91,222],"antiproliferative":[92],"activity":[93,225],"lines":[97],"half-maximal":[99],"inhibitory":[100],"concentration":[101],"values":[102],"ranging":[103],"from":[104],"33":[105],"762":[107],"nM.":[108],"strongly":[112],"suppressing":[117],"tumor":[118,145,208],"proliferation":[120],"inhibiting":[122],"phosphorylation":[123,192],"extracellular":[126],"signal-regulated":[127],"(ERK).":[129],"prolonged":[132],"survival":[133],"Hep3B":[135,165],"xenografts,":[136,166],"murine":[137],"Hepa129":[138],"allografts,":[139],"MH3924A":[141,168],"rat":[142],"allografts.":[143,169],"Additionally,":[144],"growth,":[146],"ascites":[147],"formation,":[148],"serum":[150],"alpha-fetoprotein":[151],"levels":[152],"reduced.":[154],"Synergistic":[155],"shown":[162],"Huh-7,":[164],"On":[170],"level,":[174],"led":[182],"inhibition":[184,204],"upregulatory":[187],"feedback":[188],"loop":[189],"toward":[190],"MEK":[191],"observed":[193,215],"after":[194],"monotreatment.":[197],"With":[198],"regard":[199],"MoA,":[203],"ERK":[206],"phosphorylation,":[207],"proliferation,":[210],"microvessel":[212],"density":[213],"vivo.":[217],"CONCLUSION:":[218],"shows":[221],"single-agent":[223],"antitumor":[224],"acts":[227],"synergistically":[228],"preclinical":[234],"models.":[236],"These":[237],"results":[238],"support":[239],"ongoing":[241],"clinical":[242],"development":[243],"advanced":[250],"HCC.":[251]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}